Command Palette

Search for a command to run...

Clinical Trials · NCT02931474

Impact of GHRH on Sleep Promotion and Endocrine Regulation in Service Members Who Sustained a Traumatic Brain Injury and Have Current Insomnia

WithdrawnPhase 2Tesamorelin (Prohibited)
Phase
Phase 2
Recruitment status
Withdrawn
Sponsor
National Institute of Nursing Research (NINR)
Enrollment
0
Start date
Oct 2016
Locations
See registry
Primary endpoint
Change in NREM time following tesamorelin administration compared to placebo
View Tesamorelin compound reference